Capital International Inc’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Capital International Inc’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,653	Closed	-$587K	–	300
2021 Q4	$587K	Sell	10,653 -16,740	-61%	-$873K	0.01%	288
2021 Q3	$1.44M	Hold	27,393	–	–	0.01%	269
2021 Q2	$1.89M	Buy	27,393 +7,147	+35%	+$545K	0.02%	264
2021 Q1	$1.56M	Sell	20,246 -647	-3%	-$59.6K	0.01%	267
2020 Q4	$2.07M	Buy	+20,893	New	+$2.55M	0.02%	248

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital International Inc's LKFT Position: Q1 2022 in Review

Capital International Inc sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2022, closing a stake of 10,653 shares — an estimated $587K sold.

Capital International Inc first reported a position in LKFT in Q4 2020 and held it in 5 quarters. The position peaked at $2.07M in Q4 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2022.

Capital International Inc reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Capital International Inc sold 10,653 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2022, an estimated $587K.
Capital International Inc first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2020 and held it in 5 quarters.
Capital International Inc's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.07M in Q4 2020.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2022.

Based on Capital International Inc's 13F filing for Q1 2022, filed 16 May 2022.